CIK: 0001856083 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value ($000): $2,994,349 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 5,350,000 | $165,797 | 5.5% | $19.36 | +33.9% | COM PAR $.01 | 457669307 |
| — | SPRINGWORKS THERAPEUTICS INC | 4,063,676 | $148,324 | 5.0% | $28.83 | — | COM | 85205L107 |
| — | INTRA-CELLULAR THERAPIES INC | 2,000,000 | $143,240 | 4.8% | $53.32 | — | COM | 46116X101 |
| GH | GUARDANT HEALTH INC | 5,000,000 | $135,250 | 4.5% | $31.53 | -16.8% | COM | 40131M109 |
| ARGX | ARGENX SE | 300,000 | $114,129 | 3.8% | $380.43 | — | SPONSORED ADR | 04016X101 |
| CYTK | CYTOKINETICS INC | 1,347,300 | $112,486 | 3.8% | $36.21 | 0.0% | Call | 23282W605 |
| ALKS | ALKERMES PLC | 4,000,000 | $110,960 | 3.7% | $27.60 | -5.9% | SHS | G01767105 |
| PLRX | PLIANT THERAPEUTICS INC | 5,750,000 | $104,133 | 3.5% | $21.85 | -30.4% | COM | 729139105 |
| — | DYNAVAX TECHNOLOGIES CORP | 7,093,214 | $99,163 | 3.3% | $10.51 | — | COM NEW | 268158201 |
| AXSM | AXSOME THERAPEUTICS INC | 1,000,000 | $79,590 | 2.7% | $74.42 | -10.2% | COM | 05464T104 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,631,728 | $79,099 | 2.6% | $18.32 | -13.8% | COM | 92790C104 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 11,869,297 | $76,438 | 2.6% | $1.90 | — | SPON ADS | 05280R100 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 7,000,000 | $68,670 | 2.3% | $10.66 | -23.3% | COM | 69404D108 |
| NTLA | INTELLIA THERAPEUTICS INC | 2,250,000 | $68,603 | 2.3% | $42.47 | -32.3% | COM | 45826J105 |
| TVTX | TRAVERE THERAPEUTICS INC | 7,370,000 | $66,256 | 2.2% | $24.03 | -69.7% | COM | 89422G107 |
| APGE | APOGEE THERAPEUTICS INC | 2,323,456 | $64,917 | 2.2% | $22.03 | -9.0% | COM | 03770N101 |
| — | VERONA PHARMA PLC | 3,187,415 | $63,366 | 2.1% | $12.01 | — | SPONSORED ADS | 925050106 |
| IONS | IONIS PHARMACEUTICALS INC | 1,249,068 | $63,190 | 2.1% | $39.47 | +21.4% | COM | 462222100 |
| BCYC | BICYCLE THERAPEUTICS PLC | 3,490,506 | $63,108 | 2.1% | $36.63 | — | SPONSORED ADS | 088786108 |
| GERN | GERON CORP | 29,583,449 | $62,421 | 2.1% | $2.58 | -24.6% | COM | 374163103 |
| EDIT | EDITAS MEDICINE INC | 5,473,086 | $55,442 | 1.9% | $8.64 | +1.6% | COM | 28106W103 |
| — | AMBRX BIOPHARMA INC | 3,710,412 | $52,836 | 1.8% | $14.24 | — | COM | 641871108 |
| SRPT | SAREPTA THERAPEUTICS INC | 500,000 | $48,215 | 1.6% | $95.93 | 0.0% | COM | 803607100 |
| — | TOURMALINE BIO INC | 1,815,854 | $47,539 | 1.6% | $26.18 | — | COM | 89157D105 |
| — | HILLEVAX INC | 2,900,000 | $46,545 | 1.6% | $13.45 | — | COM | 43157M102 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 2,284,372 | $46,281 | 1.5% | $19.33 | -31.9% | COM | 35104E100 |
| ABVX | ABIVAX SA | 4,297,438 | $45,983 | 1.5% | $10.70 | — | SPONSORED ADS | 00370M103 |
| — | RAPT THERAPEUTICS INC | 1,793,966 | $44,580 | 1.5% | $19.48 | — | COM | 75382E109 |
| ANAB | ANAPTYSBIO INC | 2,036,990 | $43,632 | 1.5% | $18.46 | -6.6% | COM | 032724106 |
| IMVT | IMMUNOVANT INC | 1,000,000 | $42,130 | 1.4% | $6.72 | +447.3% | COM | 45258J102 |
| SYRE | SPYRE THERAPEUTICS INC | 1,952,760 | $42,023 | 1.4% | $13.78 | 0.0% | COM NEW | 00773J202 |
| OCUL | OCULAR THERAPEUTIX INC | 9,230,769 | $41,169 | 1.4% | $2.96 | 0.0% | COM | 67576A100 |
| ACLX | ARCELLX INC | 725,145 | $40,246 | 1.3% | $45.11 | 0.0% | COMMON STOCK | 03940C100 |
| TERN | TERNS PHARMACEUTICALS INC | 6,100,000 | $39,589 | 1.3% | $7.29 | -27.4% | COM | 880881107 |
| SLN | SILENCE THERAPEUTICS PLC | 1,951,580 | $33,899 | 1.1% | $16.79 | — | ADS | 82686Q101 |
| — | ORCHARD THERAPEUTICS PLC | 2,041,670 | $33,585 | 1.1% | $7.73 | — | SPON ADS NEW | 68570P200 |
| NUVL | NUVALENT INC | 450,000 | $33,116 | 1.1% | $61.88 | 0.0% | COM | 670703107 |
| ANIP | ANI PHARMACEUTICALS INC | 600,000 | $33,084 | 1.1% | $47.91 | +14.9% | COM | 00182C103 |
| NRIX | NURIX THERAPEUTICS INC | 2,997,830 | $30,938 | 1.0% | $11.16 | -38.6% | COM | 67080M103 |
| EWTX | EDGEWISE THERAPEUTICS INC | 2,537,176 | $27,757 | 0.9% | $10.10 | -30.5% | COM | 28036F105 |
| OLMA | OLEMA PHARMACEUTICALS INC | 1,930,894 | $27,090 | 0.9% | $10.19 | +31.8% | COM | 68062P106 |
| DYN | DYNE THERAPEUTICS INC | 2,000,000 | $26,600 | 0.9% | $12.12 | -19.4% | COM | 26818M108 |
| — | AGENUS INC | 31,697,539 | $26,242 | 0.9% | $2.11 | — | COM NEW | 00847G705 |
| CYTK | CYTOKINETICS INC | 288,949 | $24,124 | 0.8% | $36.21 | 0.0% | COM NEW | 23282W605 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1,062,881 | $23,670 | 0.8% | $24.02 | -6.7% | COM | 00847X104 |
| — | REPARE THERAPEUTICS INC | 2,992,731 | $21,847 | 0.7% | $17.83 | — | COM | 760273102 |
| SRRK | SCHOLAR ROCK HLDG CORP | 1,011,829 | $19,022 | 0.6% | $10.43 | +19.1% | COM | 80706P103 |
| PRTA | PROTHENA CORP PLC | 500,000 | $18,170 | 0.6% | — | — | Call | G72800108 |
| GPCR | STRUCTURE THERAPEUTICS INC | 300,000 | $12,228 | 0.4% | $23.79 | — | SPONSORED ADS | 86366E106 |
| ZURA | ZURA BIO LTD | 2,523,000 | $11,782 | 0.4% | $8.03 | -37.8% | CLASS A ORD SHS | G9TY5A101 |
| — | NEKTAR THERAPEUTICS | 18,400,000 | $10,396 | 0.3% | $0.59 | — | COM | 640268108 |
| PRTA | PROTHENA CORP PLC | 250,000 | $9,085 | 0.3% | — | — | Put | G72800108 |
| RLMD | RELMADA THERAPEUTICS INC | 2,044,507 | $8,464 | 0.3% | $10.86 | -72.7% | COM | 75955J402 |
| — | ALLAKOS INC | 2,510,736 | $6,854 | 0.2% | $2.73 | — | COM | 01671P100 |
| SYRS | SYROS PHARMACEUTICALS INC | 828,485 | $6,454 | 0.2% | $3.74 | -8.5% | COM NEW | 87184Q206 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 275,201 | $6,310 | 0.2% | $17.50 | 0.0% | COM | 74366E102 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 48,280 | $5,938 | 0.2% | $142.14 | -12.2% | SHS USD | G50871105 |
| — | VIGIL NEUROSCIENCE INC | 1,594,931 | $5,391 | 0.2% | $8.83 | — | COM | 92673K108 |
| — | ALIGOS THERAPEUTICS INC | 6,102,770 | $4,052 | 0.1% | $0.66 | — | COM | 01626L105 |
| GHRS | GH RESEARCH PLC | 499,400 | $2,897 | 0.1% | $21.97 | -67.9% | ORDINARY SHARES | G3855L106 |